Wilmington Savings Fund Society’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18
Closed -$2.24K 1910
2025
Q2
$2.24K Hold
18
﹤0.01% 1887
2025
Q1
$2.29K Hold
18
﹤0.01% 1895
2024
Q4
$2.59K Hold
18
﹤0.01% 1895
2024
Q3
$2.68K Buy
+18
New +$2.58K ﹤0.01% 1865
2017
Q3
Sell
-6,280
Closed -$260K 348
2017
Q2
$260K Sell
6,280
-240
-4% -$9.12K 0.02% 297
2017
Q1
$230K Sell
6,520
-760
-10% -$24.1K 0.01% 299
2016
Q4
$225K Sell
7,280
-825
-10% -$25.5K 0.01% 302
2016
Q3
$245K Hold
8,105
0.02% 296
2016
Q2
$222K Sell
8,105
-795
-9% -$20.3K 0.01% 306
2016
Q1
$238K Buy
8,900
+290
+3% +$7.1K 0.02% 307
2015
Q4
$243K Buy
+8,610
New +$248K 0.02% 307

Other funds holding RGEN

Wilmington Savings Fund Society's RGEN Position: Q3 2025 in Review

Wilmington Savings Fund Society sold out of Repligen (RGEN) in Q3 2025, closing a stake of 18 shares — an estimated $2.24K sold.

Wilmington Savings Fund Society first reported a position in RGEN in Q4 2015 and held it in 11 quarters. The position peaked at $260K in Q2 2017. 452 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Wilmington Savings Fund Society reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 18 Repligen shares in Q3 2025, an estimated $2.24K.
  • Wilmington Savings Fund Society first reported a position in Repligen in Q4 2015 and held it in 11 quarters.
  • Wilmington Savings Fund Society's Repligen position peaked at $260K in Q2 2017.
  • 452 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q3 2025, filed 28 Oct 2025.